CD8A and lymphoma: In the murine model, in vivo CTL activity against inoculated OVAp-expressing EL4-EG7 lymphoma cells in B6 mice was examined for NTeff, MTeff, and TILeff CD8+ effector subsets obtained from OT-1 Thy1.1 mice.